Bio-Partnering North America, Vancouver, February 2011

John Illingworth, Managing Director Illingworth Research, flew across to Vancouver to attend the Bio-Partnering North America event on 28th February 2011. Over 800 delegates, from 500 companies and 27 countries heard keynote addresses from top decision-makers at Merck, AstraZeneca and Pfizer and an in-depth market analysis from Deloitte Recap.

The positive tone of the keynote addresses, a boost in delegate attendance and the record number of pharmaceutical companies involved in BPN 2011 has created an upbeat outlook for partnering in 2011.

Comments are closed.